stockrowAtriCure, Inc. (ATRC) vs Pulse Biosciences, Inc (PLSE)
- AtriCure, Inc. ATRC 60.70 −7.37%
- Pulse Biosciences, Inc PLSE 53.15 −6.85%
AtriCure, Inc. and Pulse Biosciences, Inc are both Medical Instruments & Supplies companies. Pulse Biosciences, Inc is the larger, with a market value of $3.9B against $3.1B — 1.2× the size. Pulse Biosciences, Inc has negative trailing earnings, so its P/E is not meaningful; AtriCure, Inc. trades at 199×. Pulse Biosciences, Inc grew revenue faster over the last twelve months: 90.1% against 13.8%. AtriCure, Inc. has the higher net margin (2.52% vs −5,609.4%) and the higher return on invested capital (2.61% vs −37.0%). Across the 17 metrics below, AtriCure, Inc. leads on 14 and Pulse Biosciences, Inc on 3.
Valuation
Profitability
| Metric | ATRC | PLSE | Medical Instruments & Supplies median |
|---|---|---|---|
| Gross margin | 76.74% | 26.77% | 53.60% |
| Operating margin | 2.89% | (5,821.08%) | 1.97% |
| Net margin | 2.52% | (5,609.44%) | 0.00% |
| Free cash flow margin | 8.98% | (14,462.52%) | 2.36% |
| Return on equity | 2.95% | (60.67%) | 0.00% |
| Return on assets | 2.20% | (54.01%) | 0.00% |
| Return on invested capital | 2.61% | (37.01%) | 0.13% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack